Institutional Ownership
Kalaris Therapeutics Inc
CUSIP 482929106COMKLRSQ1 2026
Institutional Holders
55
13F filers
Shares Held
18.29M
Aggregate institutional
Institutional Value
$105.43M
Q1 2026
Net New Holders
+6
12 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions12
Increased16
Decreased7
Sold out6
Institutional Holders
55 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Samsara Biocapital, LLC | 12.95M | $74.71M | 0 | Held |
| 2 | Rtw Investments, LP | 1.30M | $7.50M | 0 | Held |
| 3 | Paradigm Biocapital Advisors LP | 700.0K | $4.04M | 0 | Held |
| 4 | Alyeska Investment Group, L.P. | 572.7K | $3.27M | +169.1K | Added |
| 5 | Siren, L.L.C. | 435.8K | $2.51M | 0 | Held |
| 6 | Ikarian Capital, LLC | 360.0K | $2.08M | 0 | Held |
| 7 | Propel Bio Management, LLC | 295.8K | $1.72M | +253.7K | Added |
| 8 | Kalehua Capital Management LLC | 135.6K | $782.3K | −4.3K | Reduced |
| 9 | Raymond James Financial Inc | 118.9K | $686.0K | +30.5K | Added |
| 10 | Goldman Sachs Group Inc | 110.5K | $637.6K | +76.2K | Added |
45 more institutional holders on Premium
See every fund holding Kalaris Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders